| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | Director | $663K | Jun 20, 2025 | ||
| MXCT | MAXCYTE, INC. | Director | $320K | +$111K | +53.1% | Aug 13, 2025 |
| ALDX | Aldeyra Therapeutics, Inc. | Director | Jun 10, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|